Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study.
作者信息
Qazi R, Elson P, Khandekar J D
出版信息
Cancer Treat Rep. 1982 Feb;66(2):405-6.
PMID:7055823
Abstract
摘要
相似文献
1
2
Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
Cancer Treat Rep. 1977 Jan-Feb;61(1):87-8.
3
Phase II study of VM-26 in adult malignancies.
Cancer Treat Rep. 1980 Jan;64(1):147-9.
4
Phase II trial of VM-26 in patients with metastatic malignant melanoma.VM-26用于转移性恶性黑色素瘤患者的II期试验。
Cancer Treat Rep. 1978 Mar;62(3):445-7.
5
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].[使用威猛（VM-26）单药治疗泌尿道移行细胞癌]
Nihon Gan Chiryo Gakkai Shi. 1988 May 20;23(5):1046-51.
6
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.替尼泊苷治疗转移性肾癌和膀胱癌：西南肿瘤协作组研究
Cancer Treat Rep. 1987 Dec;71(12):1307-8.
7
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).
Cancer Treat Rep. 1979 Jan;63(1):7-11.
8
Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.替尼泊苷治疗上皮性卵巢癌：妇科肿瘤学组的一项II期试验
Cancer Treat Rep. 1986 Oct;70(10):1231-2.
9
Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.
Cancer Treat Rep. 1980 Jan;64(1):161-3.
10
Phase II study of teniposide in advanced breast cancer.替尼泊苷治疗晚期乳腺癌的II期研究。
Cancer Chemother Pharmacol. 1990;25(6):463-4. doi: 10.1007/BF00686061.
Zotero 插件